Study Evaluating the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis

Evaluation of the Pronostic Value of Vascular Refilling Rate on Mortality in Chronic Kidney Disease Patients on Dialysis (Stage 5D)

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04810338

Acronym

REMVAMIR

Enrollment

250

Registered

2021-03-22

Start date

2018-01-01

Completion date

2021-09-01

Last updated

2022-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Diseases

Keywords

Chronic Kidney Disease patient on dialysis (stage 5D), Extracorporeal purification, Sodium

Brief summary

Aim of this study is to evaluate in a population of chronic kidney disease patients on dialysis (Stage 5D) during an observational period of 3 years: * the prognostic value of vascular refilling rate on mortality and on the occurrence of i) cardiovascular events and ii) hospitalization number * the prognostic value of interdialytic weight gain on mortality and on the occurrence of i) cardiovascular events and ii) hospitalization number * the prognostic value of perdialytic weight loss on mortality and on the occurrence of i) cardiovascular events and ii) hospitalization number.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Chronic Kidney Disease patient on dialysis (stage 5D) since at least september 2017 (3 months prior to study start date) * Anuric patient

Exclusion criteria

\- Chronic Kidney Disease patient on dialysis with residual kidney function

Design outcomes

Primary

Measure	Time frame	Description
Prognostic value of vascular refilling rate on mortality	2 years after inclusion	The refilling rate will be assessed by the ratio of relative blood volume

Secondary

Measure	Time frame	Description
Prognostic value of interdialytic weight gain	2 years after inclusion	Prognostic value of interdialytic weight gain
Prognostic value of perdialytic weight loss	2 years after inclusion	Prognostic value of perdialytic weight loss

Countries

France

Outcome results